Neutrophil and cytokine dysregulation in hyperinsulinemic obese horses.

This study investigates the inflammatory responses in horses suffering from equine metabolic syndrome (EMS), a condition characterized by obesity and recurrent laminitis. The researchers found a strong correlation between insulin levels and increased production of harmful reactive oxygen species in immune cells. However, obese horses did not show increased activity of pro-inflammatory cytokine proteins, which differs from the response observed in humans with similar metabolic disorders.

Objective and Approach

• The study aimed at understanding the inflammatory events in horses suffering from equine metabolic syndrome (EMS). This metabolic disorder is marked by obesity and is often associated with repetitive cases of laminitis, a serious, painful foot condition in horses resulting from inflammation of sensitive tissue.
• The researchers focused on measuring key markers of inflammation, particularly around the response of neutrophils – a type of white blood cell – and the expression of cytokines, proteins that are vital to immune responses.

Key Findings

• The study found that horses with EMS showed a significant increase in the production of reactive oxygen species (ROS) by neutrophils when they are triggered to engulf and destroy pathogens – a process known as phagocytosis. ROS are harmful compounds that, if produced in excess, can cause damage to cells.
• Notably, the researchers found a strong correlation between this increased ROS production by neutrophils and the concentration of insulin in the horse’s blood. This could suggest that horses with higher levels of insulin – a state known as hyperinsulinemia, common in metabolic disorders – may have a higher risk of laminitis due to this enhanced inflammatory response.
• However, unlike in humans with similar metabolic disorders, the researchers observed that the expression of pro-inflammatory cytokines (IL-1 and IL-6) was lowered in obese, hyperinsulinemic horses. This was true for both the default state of these proteins and following induced immune stimulation.

Implications

• The findings suggest that the inflammatory response in horses with EMS is complex and distinct from that in humans. In particular, the increase in harmful ROS production by neutrophils – and its link to insulin – is a concern, but the lack of increased cytokine activity suggests a unique, species-specific response. This underscores the need for further research to better understand and manage EMS in horses.
• In addition, the difference in cytokine responses between horses and humans with similar metabolic conditions could help us understand why clinical outcomes are different between the two. Such insights could help improve treatment approaches tailored specifically to horses.